41 分钟
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD ...
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025 Financial Highlights Total Medical ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果